Compile Data Set for Download or QSAR
Report error Found 5 Enz. Inhib. hit(s) with all data for entry = 7712
TargetBeta-lactamase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Meiji Seika Pharma

US Patent
LigandPNGBDBM212440(US8772490, H)
Affinity DataIC50: 650nMpH: 7.0 T: 2°CAssay Description:For the measurement of β-lactamase inhibitory activity, 100 uM (final concentration) nitrocefin (Oxoid) was used as a substrate, and 2.5% DMSO, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2017
Entry Details
Go to US Patent

TargetBeta-lactamase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Meiji Seika Pharma

US Patent
LigandPNGBDBM159600(US9035062, 23 | US8772490, Example 23)
Affinity DataIC50: 650nMpH: 7.0 T: 2°CAssay Description:For the measurement of β-lactamase inhibitory activity, 100 uM (final concentration) nitrocefin (Oxoid) was used as a substrate, and 2.5% DMSO, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2017
Entry Details
Go to US Patent

TargetBeta-lactamase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Meiji Seika Pharma

US Patent
LigandPNGBDBM212441(US8772490, TAZ)
Affinity DataIC50: 950nMpH: 7.0 T: 2°CAssay Description:For the measurement of β-lactamase inhibitory activity, 100 uM (final concentration) nitrocefin (Oxoid) was used as a substrate, and 2.5% DMSO, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2017
Entry Details
Go to US Patent

TargetBeta-lactamase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Meiji Seika Pharma

US Patent
LigandPNGBDBM159601(US9035062, 24 | US8772490, Example 24)
Affinity DataIC50: 3.00E+4nMpH: 7.0 T: 2°CAssay Description:For the measurement of β-lactamase inhibitory activity, 100 uM (final concentration) nitrocefin (Oxoid) was used as a substrate, and 2.5% DMSO, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2017
Entry Details
Go to US Patent

TargetBeta-lactamase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Meiji Seika Pharma

US Patent
LigandPNGBDBM159601(US9035062, 24 | US8772490, Example 24)
Affinity DataIC50: 3.00E+4nMpH: 7.0 T: 2°CAssay Description:For the measurement of β-lactamase inhibitory activity, 100 uM (final concentration) nitrocefin (Oxoid) was used as a substrate, and 2.5% DMSO, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2017
Entry Details
Go to US Patent